| Date Filed | Type | Description |
| 01/31/2023 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 12,200 shares
@ $0
Granted 20,000 options to buy
@ $18.4, valued at
$368k
|
|
| 01/03/2023 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,600 shares
@ $12.37, valued at
$19.8k
|
|
| 09/06/2022 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 597 shares
@ $18.06, valued at
$10.8k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 171 shares
@ $15.93, valued at
$2.7k
|
|
| 02/15/2022 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 529 shares
@ $14.85, valued at
$7.9k
|
|
| 01/31/2022 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 10,300 shares
@ $0
Granted 17,600 options to buy
@ $14.44, valued at
$254.1k
|
|
| 01/04/2022 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,211 shares
@ $16.29, valued at
$19.7k
|
|
| 11/17/2021 |
4
| Richardson Linda M (EVP & Chief Commercial Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 171 shares
@ $17.67, valued at
$3k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/15/2018 |
4
| Richardson Linda M (Chief Commercial Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Paid exercise price by delivering 4,545 shares
@ $4.6643, valued at
$21.2k
|
|
| 02/05/2018 |
4
| Richardson Linda M (Chief Commercial Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Paid exercise price by delivering 2,290 shares
@ $4.6684, valued at
$10.7k
|
|
| 01/29/2018 |
4
| Richardson Linda M (Chief Commercial Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 135,000 options to buy
@ $4.68, valued at
$631.8k
|
|
| 12/05/2017 |
4
| Richardson Linda M (Chief Commercial Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Sold 19,833 shares
@ $4.471, valued at
$88.7k
|
|
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2016 |
4
| Richardson Linda M (Chief Commerical Officer) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 60,000 shares
@ $0 |
|